Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Cipla Ltd.
NSE: CIPLA
|
BSE: 500087
|
ISIN: INE059A01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
1511.6000
10.70
(
0.71
%)
NSE
Jan 02, 2026
15:31 PM
Volume:
964.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cipla Ltd.
27 Oct 2021
1511.60
0.71%
Cipla (BUY): Results better than expected; EBITDA margin resilient
Buy:
Cipla Ltd.
by
BOB Capital Markets Ltd.
Target: 1160
Target
BOB Capital Markets Ltd.
Q2 revenue/EBITDA grew 10%/4% YoY to Rs 55bn/Rs 12bn, beating our estimates by 6%/4%
Cipla Ltd. has an
average target
of 1697.44 from 9 brokers.
More from Cipla Ltd.
Recommended
Five Interesting Stocks Today - January 2, 2026
The Baseline |
02 Jan 2026, 05:55PM
Market closes higher, led by a rally in auto stocks
Trendlyne Marketwatch |
02 Jan 2026, 04:04PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
|
20 May 2022